Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 12, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
05:18

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

Published on: June 9, 2020

11.9K

Rubella in Poland in 2014

Iwona Paradowska-Stankiewicz1, Justyna Rogalska2, Aleksandra Polkowska3

  • 1National Institute of Public Health-National Institute of Hygiene, Department of Epidemiology

Przeglad Epidemiologiczny
|November 18, 2016
PubMed
Summary

Poland saw a significant decrease in rubella cases in 2014, with no congenital rubella syndrome reported. However, laboratory confirmation of rubella infection remains very low.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Lyme disease in Poland in 2023.

Przeglad epidemiologiczny·2026
Same authorSame journal

Pertussis in Poland in 2023.

Przeglad epidemiologiczny·2026
Same author

Dose-dependent impact of extremely low-frequency electromagnetic field (ELF-EMF) on the neuroplasticity in the hippocampus of adult rats.

Neuroscience letters·2026
Same author

Public spending on immunisation in Poland.

Frontiers in public health·2025
Same author

Chickenpox in Poland in 2023.

Przeglad epidemiologiczny·2025
Same author

Mumps in Poland in 2023.

Przeglad epidemiologiczny·2025

Area of Science:

  • Epidemiology
  • Public Health
  • Vaccinology

Background:

  • Poland adopted the WHO goal for rubella elimination and congenital rubella syndrome prevention in 2004.
  • Rubella vaccination was introduced in 1987 and a combined MMR vaccine has been used since 2003.
  • Clinical diagnosis and laboratory confirmation are required for rubella case reporting in Poland.

Purpose of the Study:

  • To assess the epidemiological situation of rubella in Poland in 2014.
  • To evaluate vaccination coverage within the Polish population.
  • To monitor progress towards rubella elimination goals.

Main Methods:

  • Descriptive analysis of mandatory surveillance data.
  • Utilized data from annual bulletins on infectious diseases and vaccinations in Poland for 2014.

More Related Videos

Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

5.7K

Related Experiment Videos

Last Updated: Mar 12, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
05:18

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

Published on: June 9, 2020

11.9K
Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

5.7K
  • Reviewed case reports and incidence rates from the national surveillance system.

    • Main Results:

    • A significant decrease in rubella cases was observed in 2014 (5,891 cases) compared to 2013 (38,548 cases).
    • Rubella incidence declined from 101.1 to 15.3 per 100,000 population.
    • No cases of congenital rubella syndrome were registered in 2014; incidence was highest in 5-6 year olds.
    • Male rubella incidence (20.0) was higher than in females (10.9).

    Conclusions:

    • While rubella incidence decreased significantly, the proportion of laboratory-confirmed rubella cases remains very low (0.6% in 2014).
    • Continued surveillance and improved laboratory confirmation are crucial for effective rubella elimination efforts.
    • The data indicates progress towards rubella elimination but highlights challenges in diagnostic confirmation.